Key facts
- This page summarizes John B. Bode's Form 3 filing for ZEVRA THERAPEUTICS, INC. (ZVRA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 May 2023, 21:39.
John B. Bode - 25 Apr 2023 Form 3 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)
- Reporting relationship
- Director
- Issuer ticker
- ZVRA
- Reported as of
- 25 Apr 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 08 May 2023, 21:39:59 UTC
- Prior SEC filing
- 28 Dec 2021
- Next SEC filing
- 08 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John B. Bode filed Form 3 for ZEVRA THERAPEUTICS, INC. (ZVRA) on 08 May 2023.
Change
- Previous filing in this sequence was filed on 28 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney